hydrochlorothiazide
TRANSCRIPT
Content Hydrochlorothiazide
Dosage Forms & Trade Names
Pharmacokinetics Ι & ΙΙ Mechanism of action
Action
Therapeutic uses
Adverse effects
Contraindication & Drug Interaction
Pregnancy & Lactation
Overdose
2
HydrochlorothiazideHCTZ, HCT, or HZT
The thiazides are the most widely used diuretics.
They are sulfonamide derivatives.
Sometimes called “low ceiling diuretics” because increasing the dose above normal therapeutic doses doesn't promote further diuretic response.
Because the site of action of the thiazide derivatives is on the luminal membrane, these drugs must be excreted into the tubular lumen to be effective.
Therefore, with decreased renal function, thiazide diuretics lose efficacy.
3
Dosage Forms & Trade Names
Trade Names: Microzide, HydroDiuril, Hydro, Esidrix
Dosage Forms: Tablet, Capsule, Solution.
Tablet/Capsule: 12.5 mg, 25 mg, 50 mg
4
Co-Diovan: Valsartan – Hydrochlorothiazide (ARB+Thiazide)
Pharmacokinetics 𝚰
The drugs are effective orally.
Most thiazides take 1 to 3 weeks to produce a
stable reduction in blood pressure.
They exhibit a prolonged half-life.
All thiazides are secreted by the organic acid
secretory system of the kidney.
5
Pharmacokinetics 𝚰𝚰 Absorption
Onset: Diuresis, ~2 hr; hypertension, 3-4 days Peak plasma time: 1-2.5 hr Peak effect: Diuresis, 4-6 hr Bioavailability: 65-75%
Distribution Protein bound: 40-68% Vd: 3.6-7.8 L/kg
Metabolism Minimally metabolized
Elimination Half-life: 5.6-14.8 hr Dialyzable: Hemodialysis, no Excretion: Urine
6
Mechanism of action
7
www.youtube.com/watch?v=oh0nAyW5r5Y
Action
Increased excretion of Na+ and Cl−.
Loss of K+.
Loss of Mg++: The mechanism for the magnesuriais not understood.
Decreased urinary calcium excretion.
Reduced peripheral vascular resistance: An initial reduction in blood pressure results from a decrease in blood volume and, therefore, a decrease in cardiac output.
8
Therapeutic uses Chronic edema
Mild & moderate cardiac edema.
Ascites due to cirrhosis.
Hypertension:
Decrease intravascular volume
Decrease PVR due to decrease responsiveness of vascular smooth muscle to noradrenaline.
Heart failure.
Hypercalciuria:
Inhibit urinary Ca2+ excretion
Idiopathic hypercalciuria
Calcium oxalate stones.
Diabetes insipidus:
Hyperosmolar urine.
Nephrogenic diabetes insipidus.
The urine volume of such individuals may drop from 11 L/d to about 3 L/d when treated with the drug.
9
Adverse effects Potassium depletion:
Digoxin to ventricular arrhythmias.
Hyponatremia:
Elevation of ADH as a result of hypovolemia.
Hyperuricemia:
Decreasing the amount of acid excreted by the organic acid secretory system.
Volume depletion:
Orthostatic hypotension.
Hypercalcemia:
Inhibit the secretion of Ca2+.
Hyperglycemia:
Glucose intolerance
10
Contraindication & Drug
Interaction Contraindication:
Anuria
Hypersensitivity to this product or to other sulfonamide-derived drugs.
Renal impairment: CrCl <10 mL/min: Avoid use.
not effective with CrCl <30 mL/min unless used in combination with loop diuretic.
Drug Interaction: (Serious - Use Alternative) Amisulpride
Carbamazepine
Cisapride
Cyclosporine
Dofetilide
Squill
tretinoin
11
Pregnancy & Lactation
Pregnancy Category: B Thiazides are indicated in pregnancy when edema is due
to pathologic causes.
Not used in dependent edema in pregnancy
Lactation:
Thiazides are excreted in breast milk.
Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue Hydrochlorothiazide.
12
Overdose Overdose signs and symptoms :
hypokalemia, hyponatremia.
Dehydration.
hypokalemia may accentuate cardiac arrhythmias.
Overdose management: Normal saline used for volume replacement. Dopamine or norepinephrine used to treat hypotension.
If dysrhythmia due to decreased potassium or magnesium is suspected, replace aggressively.
Emesis should be induced or gastric lavage performed.
If required, give oxygen or artificial respiration for respiratory impairment.
Lethal Dose: The oral LD50 of Hydrochlorothiazide is greater than 10
g/kg in the mouse and rat.
13
References Katzung & Trevor's Pharmacology Examination
and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review), ISBN-13: 978-0071789233
Lippincott Illustrated Reviews: Pharmacology 6th edition (Lippincott Illustrated Reviews Series), ISBN-13: 978-1451191776
www.drugs.com
www.reference.medscape.com
www.nlm.nih.gov
www.webmd.com
www.medicinenet.com
www.youtube.com/watch?v=oh0nAyW5r5Y
14